Ampio Pharmaceuticals (AMPE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,222 | -3,667 | -15,894 | -11,277 | -7,910 |
| Depreciation Amortization | 568 | 294 | 1,177 | 885 | 591 |
| Accounts receivable | 1,386 | N/A | N/A | N/A | -1,758 |
| Other Working Capital | 133 | -869 | -1,441 | -1,657 | -1,481 |
| Other Operating Activity | -1,340 | 95 | 1,429 | 200 | 1,415 |
| Operating Cash Flow | $-6,475 | $-4,147 | $-14,729 | $-11,849 | $-9,143 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -81 | -81 | -63 | -48 | N/A |
| Investing Cash Flow | $-81 | $-81 | $-63 | $-48 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,759 | 2,819 | 26,974 | 15,599 | 7,453 |
| Other Financing Activity | 0 | -133 | -1,368 | -873 | 0 |
| Financing Cash Flow | $9,759 | $2,686 | $25,606 | $14,726 | $7,453 |
| Beginning Cash Position | 17,346 | 17,346 | 6,532 | 6,532 | 6,532 |
| End Cash Position | 20,549 | 15,804 | 17,346 | 9,361 | 4,842 |
| Net Cash Flow | $3,203 | $-1,542 | $10,814 | $2,829 | $-1,690 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,475 | -4,147 | -14,729 | -11,849 | -9,143 |
| Capital Expenditure | -81 | -81 | -63 | -48 | N/A |
| Free Cash Flow | -6,556 | -4,228 | -14,792 | -11,897 | -9,143 |